Similarly, in the “other suspected viral infection” group, patients whose EBV status was initially interpreted as early primary infection or convalescent phase were also reclassified as either seronegative or having a past infection, following the loss of VCA IgM reactivity after HBT pretreatment. This evidence concerns the gene CD40LG and viral infectious disease.